Caricamento...
Immune checkpoint inhibitors in genitourinary malignancies
Although immune-mediated therapies have been used in genitourinary (gu) malignancies for decades, recent advances with monoclonal antibody checkpoint inhibitors (cpis) have led to a number of promising treatment options. In renal cell carcinoma (rcc), cpis have been shown to have benefit over conven...
Salvato in:
| Pubblicato in: | Curr Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Multimed Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194001/ https://ncbi.nlm.nih.gov/pubmed/32368176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5121 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|